Hepion Pharmaceuticals, Inc.
Recent Filings
All 658 filings →| Form | Description | Date |
|---|---|---|
| 3 | 3 | Mar 18, 2026 |
| 3 | 3 | Mar 18, 2026 |
| 3 | — | Mar 18, 2026 |
| 8-K | 8-K | Mar 18, 2026 |
| 10-K | 10-K | Mar 12, 2026 |
| 8-K | 8-K | Mar 3, 2026 |
| 8-K | 8-K | Jan 15, 2026 |
| 10-Q | 10-Q | Nov 12, 2025 |
| SCHEDULE 13G/A | — | Aug 14, 2025 |
| SCHEDULE 13G/A | — | Aug 14, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Wijngaard Peter | — | Purchase | 2,500 @ $3.09 | 7,001 | Nov 27, 2023 |
| Wijngaard Peter | — | Purchase | 1,000 @ $5.82 | 2,501 | Sep 19, 2023 |
| Foster Robert T | CEO and Director | Purchase | 1,600 @ $5.60 | 50,470 | Sep 18, 2023 |
| Foster Robert T | CEO,CSO and Director | Purchase | 1,600 @ $5.40 | 48,870 | Sep 15, 2023 |
| Foster Robert T | CEO and Director | Purchase | 20,000 @ $2.00 | 45,259 | Feb 18, 2021 |
| Cavan John T | Chief Financial Officer | Purchase | 10,000 @ $2.00 | 14,800 | Feb 18, 2021 |
| Wijngaard Peter | — | Purchase | 10,000 @ $2.20 | 30,000 | Feb 16, 2021 |
| Wijngaard Peter | — | Purchase | 20,000 @ $1.91 | 20,000 | Dec 18, 2020 |
| Foster Robert T | CEO and Director | Purchase | 25,000 @ $1.58 | 25,259 | Dec 8, 2020 |
| BRANCACCIO JOHN P | — | Purchase | 7,000 @ $1.53 | 7,008 | Dec 2, 2020 |